High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of <i>BRCA1/2</i> Pathogenic Variants: Prevalence and Clinical Factors
Iris A.S. Stroot(University Medical Center Groningen), Katja N. Gaarenstroom(Radboud University Nijmegen), Marian J.E. Mourits(Radboud University Nijmegen), B.F.M. Slangen(Maastricht University Medical Centre), Marjanka K. Schmidt(University of Cambridge), Denise J. Stommel-Jenner(The Netherlands Cancer Institute), Harry Hollema(University Medical Center Groningen), Luc R.C.W. van Lonkhuijzen(University of Amsterdam), Joanne A. de Hullu(Radboud University Nijmegen), Ingrid Boere(Erasmus MC Cancer Institute), Margreet G.E.M. Ausems(McGill University Health Centre), Christi J. van Asperen(Loyola University Medical Center), Marc van Beurden(Oncode Institute), Ronald P. Zweemer(Cancer Genomics Centre), Joost Bart(University Medical Center Groningen), Geertruida H. de Bock(University Medical Center Groningen), Helena C. van Doorn, Klaartje van Engelen(Amsterdam UMC Location University of Amsterdam), Marise M. Wagner(University Medical Center Groningen), Marijke R. Wevers(Radboud University Nijmegen), E. Gómez(Maastricht University Medical Centre), Jan Brouwer(University Medical Center Groningen)
Cited by 14
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
|JNCI Journal of the National Cancer Institute|2015|570